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A Dynamic Epigenome
Because traditional methods only provide a static picture of the 
chromatin landscape, it is not surprising that Steve Henikoff 
(Fred Hutchinson Cancer Research Center, Seattle), who gave 
the first talk, chose to summarize efforts from his lab to develop 
newer methodologies that allow the study of a highly dynamic 
epigenome at single base pair resolution. He started by explain-
ing that by combining the use of standard MNase digestion and 
paired-end sequencing to map the budding yeast epigenome, his 
group was able to characterize DNA-binding features of more 
than a hundred transcription factors, identifying protected and 
exposed regions around the binding site of each of them.1 In 
another example, he explained that by using the “CATCH-IT” 
method for the study of the Drosophila genome, they showed 
that the rate of nucleosome turnover is faster at sites bound by 
Trithorax group proteins than at sites bound by Polycomb-group 
proteins;2 a difference that is likely to be important for epig-
enome maintenance and gene regulation. Henikoff also studied 
the chromatin landscape before and after heat shock using S2 
cells. These studies provided an extraordinarily detailed genome-
wide view of RNAP II pausing and nucleosome turnover.3 
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With the goal of discussing how epigenetic control and 
chromatin remodeling contribute to the various processes that 
lead to cellular plasticity and disease, this symposium marks 
the collaboration between the institut national de la Santé et 
de la Recherche Médicale (inSERM) in France and the University 
of California, irvine (UCi). organized by paolo Sassone-Corsi 
(UCi) and held at the Beckman Center of the national Academy 
of Sciences at the UCi campus December 15–16, 2011, this was 
the first of a series of international conferences on epigenetics 
dedicated to the scientific community in Southern California. 
the meeting also served as the official kick off for the newly 
formed Center for Epigenetics and Metabolism at the School 
of Medicine, UCi (http://cem.igb.uci.edu).
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Finally, he described a method that employs in vivo biotin label-
ing of nuclear envelope proteins present in individual cell types 
that allowed the purification of nuclei from different cell types in 
Arabidopsis for the analysis of cell-specific gene expression pat-
terns and chromatin features.4 Recently, the same method was 
used to isolate nuclei from muscle and non-muscle cells of adult 
C. elegans.5 Henikoff and colleagues were able to identify genes 
that are specifically expressed in muscle tissues and found that 
these genes are depleted of nucleosomes at promoters and gene 
bodies in muscle cells but not in other tissues. This method could 
potentially be applied to compare epigenetic profiles among dif-
ferent cell types or tissues within any organism.
Also interested in developing assays that facilitate the study of 
a dynamic epigenome, Peter Jones’s lab (University of Southern 
California, Los Angeles) used a single-molecule, high-resolution 
nucleosome positioning assay, called Nucleosome Occupancy 
Methylome-Sequencing (NOME-Seq),6 to demonstrate that 
active (but not inactive) non-CpG island promoters display 
a nucleosome-depleted region (NDR), something previously 
studied only at CpG island promoters. Jones explained that the 
strength of the non-CpG NDR correlates with the expression 
level of the corresponding gene and suggested that epigenetic sta-
tus of non-CpG island promoters should therefore be also taken 
into consideration in cancer studies. Jones explained that nucleo-
some occupancy precedes DNA methylation and that de novo 
DNA methylation does not occur in the absence of nucleosomes. 
Studying the process on individual DNA molecules, Jones and 
colleagues showed that the unmethylated OCT4 distal enhancer 
has a NDR that is maintained by binding of OCT4, which is 
itself required for OCT4 expression. Interestingly, de novo meth-
ylation follows the loss of the NDR, stabilizing a silenced con-
figuration of the gene.7 In a different example, Jones described his 
MYOD1 studies.8 The MYOD1 gene is repressed by Polycomb-
group proteins and is autoregulated (having binding sites for the 
protein it codes for in its enhancer and promoter). He observed 
that a NDR is characteristic of an expressing MYOD1 promoter. 
Exogenous MYOD1 activates its own transcription by binding 
first to the MYOD enhancer, which leads to a NDR at the pro-
moter. Interestingly, cells that normally express MYOD1 (human 
rhabdomyosarcoma cell line) and cells in which MYOD1 is 
repressed (normal human fibroblast cell line) respond differently 
to forced expression of MYOD1 than cells in which MYOD1 is © 2012 Landes Bioscience.
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pioneer in this type of work, Bing Ren (University of California, 
San Diego) described efforts from his lab toward the identifi-
cation of tissue-specific gene expression programs by genome-
wide prediction of enhancers, promoters and insulators. A few 
years ago, his lab identified specific chromatin signatures pres-
ent at different cis-regulatory regions.9 Now, they have begun 
to systematically map these signatures in a genome-wide scale. 
Ren and colleagues performed the first survey of this kind using 
a ChIP-seq approach on 20 mouse tissues. Ren reported the 
identification of almost 300,000 regulatory sequences in the 
genome, the majority of which were confirmed by reporter assay 
arrays. These newly identified cis-elements provide annotation 
for 11% of the mouse genome, which represent a significantly 
larger portion than that occupied by protein-coding sequences. 
They could also associate putative enhancers with tissue-specific 
chromatin modifications and with the enrichment for lineage-
specific transcription-binding motifs. Interestingly, out of 206 de 
novo motifs, 126 appear to match a known transcription binding 
motif and, of these, 75% have been shown to play a role in gene 
regulation in a particular tissue. Ren’s lab is also trying to under-
stand how these cis-regulatory elements are organized along the 
genome and work together in order to achieve gene regulation. 
Using Hi-C technology, which allows genome-wide analysis of 
higher order chromatin structure, he is identifying long-range 
chromatin interactions. This topological view indicates that the 
genome is composed of megabase sized topological domain struc-
tures that determine specific chromosomal territories, which con-
firm previous computational models.
Sirtuins Make an Appearance
Raul Mostoslavsky (Massachusetts General Hospital, Harvard 
Medical School, MA) and Katrin Chua (Stanford University, 
CA) moved the discussion toward sirtuins. Mostoslavsky and 
Chua talked about Sirt6, one of the seven mammalian sirtuins 
that shares homology with the yeast Sir2. Sirt6 is a chromatin-
associated protein that promotes resistance to DNA damage 
and suppresses genomic instability in mouse cells. Loss of Sirt6 
leads to an aging-like phenotype in mice that is likely to arise 
from its involvement in aging, metabolism and cancer.10 In the 
absence of Sirt6, the uptake of glucose increases significantly. 
In Sirt6 knockout cells, lactate production increases and oxygen 
consumption decreases. Sirt6 regulates H3K9 acetylation at the 
promoter of glycolytic genes, causing an increase in their tran-
scription.11 Sirt6 therefore functions as a critical regulator of glu-
cose uptake and glycolysis.12 In his talk, Mostoslavsky discussed 
some new results indicating a role for SIRT6 in the modulation of 
transcription beyond its involvement in chromatin compaction. 
Furthermore, he presented new data suggesting a role for SIRT6 
in cancer metabolism. Chua discussed ongoing work from her 
lab attempting to identify new cellular functions and contexts for 
Sirt6, in order to understand its role in physiology and disease. 
She explained that Sirt6 knockout mice die in approximately 4 
weeks due to a hypoglycemic crisis but, when provided with a 
diet rich in fat, mice are able to survive past this crisis period. She 
showed that Sirt6 is not required for blood glucose maintenance 
silenced (RKO—colorectal cancer cell line). Jones found that the 
MYOD1 enhancers in both active and repressed MYOD1 cell 
lines (but not in RKO cells) are enriched in the H3K4me1 modi-
fication, which appears to mark a “permissive” state that is recep-
tive and could potentially be activated by the binding of master 
regulatory factors. In genome-wide studies, Jones observed that 
a high percentage of Polycomb target genes have enhancers that 
acquire a permissive state, which could indicate a general mecha-
nism for the regulation of cell-fate reprogramming.
When the Epigenome Says Silence
Moving the focus of attention now to heterochromatin function 
and formation, Hiten Madhani (University of California, San 
Francisco) discussed studies from his lab investigating how non-
coding RNAs (ncRNAs) trigger heterochromatin formation. 
He presented data that identifies a conserved sequence-specific 
RNA binding protein that recognizes ncRNAs to promote silenc-
ing. This essential protein is physically recruited to centromeric 
repeat-derived ncRNAs in fission yeast and represents the molec-
ular component linking ncRNAs and the histone H3 methyl-
transferase Clr4 in an RNAi-independent pathway. He discussed 
the implications of these findings as H3K9 methylation is gener-
ally triggered in fungi and animals, where it is clear that RNAi is 
not a universal trigger of heterochromatin formation.
Heterochromatin was also the focus of Thomas Jenuwein 
(Max-Plank Institute, Freiburg, Germany), who presented work 
from his lab on the identification of transcription factor binding 
sites within major satellite repeats. Specifically, his lab showed 
that Pax3 binds to satellite repeats and represses their transcrip-
tion. In iMEF cells mutant for Pax3, he observed loss of het-
erochromatic histone methyl marks. In addition, double mutant 
cells in which Pax9 is also mutated, display massive deregula-
tion of heterochromatic transcripts, indicating that Pax3 and 
Pax9 may perform redundant functions. Pax3 and Pax9 bind in 
the vicinity of the transcription start sites within major satellite 
repeats. Jenuwein proposed an interesting model in which the 
distinction between euchromatin and heterochromatin would be 
given by the way transcription factor binding sites are organized. 
In this model, heterochromatin is crowded with transcription 
factor binding sites, but these sites are not organized in the same 
way in which they appear in euchromatin (i.e., mainly in promot-
ers and enhancers). He argued that the same transcription factors 
work in heterochromatin and euchromatin but, because in het-
erochromatin the binding sites lack the typical euchromatic orga-
nization, transcription factor binding is uncoordinated, defining 
that region to become heterochromatic (e.g., by triggering the 
recruitment of specific enzymes that modify chromatin).
Going (Epi)Genome-Wide
Identifying the epigenetic status of all genomic loci in each cell 
type at every given time is the goal of many laboratories work-
ing in the field. The potential application of this knowledge is 
enormous, including the design of diagnostic tools that could 
detect disease at earlier stages, just by analyzing the epigenome. A © 2012 Landes Bioscience.
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β-globin locus, she showed that cohesin, and the cohesin loading 
factor Nipbl, bind to the locus control region at the CTCF insu-
lator region and distal enhancer, upon differentiation. Cohesin 
binding is critical for long-range chromatin interactions between 
the enhancer and the promoter and is important for β-globin 
gene expression in human cells. Nipbl haploinsufficiency affects 
cohesin binding, altering chromatin interactions and affecting 
gene expression.
Continuing the discussion on the mechanism by which the 
epigenome regulates transcriptional activation, Jean Marc Egly 
(IGBMC, INSERM, Strasbourg, France) talked about his stud-
ies of the intriguing role of nucleosome excision repair (NER) 
factors in transcription.16 Egly explained that, upon gene acti-
vation, the RNAP II transcription machinery associates with 
NER factors at the promoter. Egly and colleagues observed that, 
in patients with silenced NER factors, the changes necessary for 
transcription to initiate (such as, H3K4me, H2K9me, H3K9/
K14ac and DNA demethylation) do not occur. Deficiencies in 
NER factors impede the recruitment of other necessary remodel-
ing factors that modify chromatin. Specifically, XPG and XPF 
appear to have a role in the formation of the necessary chromatin 
loop between the promoter and terminator.
Epigenetic Phenotypic Diversity
Joseph Ecker (HHMI and The Salk Institute for Biological 
Studies, San Diego) talked about his Arabidopsis studies of 
phenotypic diversity. His lab analyzed spontaneous changes in 
DNA methylation, which are able to produce stable epialleles 
that can modify the phenotype. Through examination of plants 
propagated by single-seed descent across 30 generations, Ecker 
and colleagues identified single methylation polymorphisms and 
CG differentially methylated regions that provide evidence for 
an epigenetic mechanism of phenotypic diversity.17 These new 
epialleles are sequence-independent, can alter transcription and 
can be transmitted to the offspring, providing evidence for an 
epigenetic mechanism of phenotypic diversity that can occur in 
the absence of genetic mutation. Ecker ended his talk with the 
interesting question of whether these events could be regulated 
by the environment.
Epigenetics of the Brain
Jean Antoine Girault (INSERM, Paris, France) discussed the 
chromatin changes involved in the response to behavioral modi-
fications. He explained that the dopamine signaling pathway is 
involved in several neurological and psychiatric disorders and 
in drug addiction. Dopamine regulates a nucleosomal response 
through a kinase/phosphatase cascade that mediates the nuclear 
accumulation of DARPP-32, a potent inhibitor of protein phos-
phatase-1. This accumulation causes phosphorylation of histone 
H3 on Ser10. Mutations in DARPP-32 alter the effect of drugs 
of abuse, which underlines the importance of DARPP-32 in this 
response.18 Girault and colleagues are currently measuring tran-
scriptional and epigenetic changes mediated by DARPP-32 using 
a series of clever tools that allow the isolation of polysomes or 
in adulthood. These longer-lived Sirt6 mice show behavioral 
defects that are reminiscent of mouse models of Alzheimer or 
autism, for example. These observations suggest a possible SIRT6 
involvement in cognition and behavior.
Signaling to and from Chromatin
Paolo Sassone-Corsi (UCI) discussed how the cellular metabolism 
and the epigenome might communicate with each other in previ-
ously unsuspected ways. Specifically, he suggested that changes 
in the levels of cellular metabolites (which are partly controlled 
by the circadian clock) could influence the epigenome. Sassone-
Corsi explained that because histone-modifying enzymes could 
“sense” the cellular metabolism, it is possible that they interpret 
the metabolic state of a cell at a given time by modifying chro-
matin in a specific cyclic manner.13 As an example, the oscillatory 
nature of NAD+ dictates oscillatory acetylation of Sirt1 targets, 
even though Sirt1 levels do not oscillate.14 An important fraction 
of the genome is transcriptionally controlled in a circadian man-
ner; it is intriguing to now start to understand how the circadian 
clock could act through the epigenome to exert its regulatory 
function.
Histone modifications signal the recruitment or activity of 
downstream effectors. The interpretation of this epigenetic sig-
nal is mediated by the so-called “readers,” which are specialized 
proteins that are able to interpret the “epigenetic language.” Or 
Gozani’s lab (Stanford University) investigates the role of lysine 
methylation in disease. At this symposium he described a high-
throughput peptide microarray assay designed to discover new 
“readers” containing chromatin-associated domains that could 
specifically recognize H4K20me2. Gozani and colleagues identi-
fied the BAH domain in Orc1 (the largest subunit of the origin 
recognition complex and previously implicated in primordial 
dwarfism) as the link between H4K20me2, Orc1 and primor-
dial dwarfism. Binding of H4K20me2 appears to be required for 
efficient loading of ORC onto chromatin. Importantly, mutation 
in the BAH domain of Orc1 is implicated in the etiology of the 
Meier-Gorlin syndrome (a primordial dwarfism syndrome), due 
to the impairment of H4K20me2 recognition. There is therefore 
a potential role for H4K20me2 in determining organism size in 
mice. Remarkably, H4K20me2 depletion in zebrafish results in 
dwarfism.
RNA molecules are also important components of the dynamic 
epigenome. Axel Imhof (Ludwig-Maimilians Universität, 
München, Germany) discussed the role that RNA molecules 
play in chromatin. He explained that the binding of RNA to in 
vitro assembled chromatin appears to “open” chromatin, and the 
removal of RNA from chromatin leads to its compaction. This 
may be due to the removal of many (RNA-dependent) factors 
from chromatin, which he analyzed using an in vitro chroma-
tin assembly system prepared from Drosophila embryos.15 In his 
talk, Imhof suggested that the formation of a chromatin associ-
ated RNP network may be responsible for maintaining an acces-
sible chromatin structure.
The role of cohesin in the regulation of gene expression was 
the topic of Kyoko Yokomori’s (UCI) talk. In studies of the © 2012 Landes Bioscience.
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downregulated in D2R presynaptic mutant mice. Further study 
of this region showed that specific repressive histone marks are 
significantly enriched in these samples, compared with samples 
from wild type animals, suggesting that dopamine might mediate 
its effects in the frontal cortex via epigenetic events. As an exam-
ple, Borrelli mentioned that the Akt1 gene, which encodes one 
of the downregulated RNAs in D2R presynaptic mutants, shows 
significant enrichment of repressive histone marks at its promoter. 
It is appealing to speculate that disorders such as schizophrenia 
could be regulated by epigenetic events.
It is always fascinating to listen to researchers talking about 
their work. But, particularly at this meeting, their enthusiasm and 
vitality was refreshing and contagious. The arrangement of speak-
ers gathered at this first Symposium on Epigenetic Control and 
Cellular Plasticity and the content of their presentations warrant 
success for many more international symposiums of this kind.
nuclei from specific cells of interest. In preliminary results, they 
observed that cocaine exerts different effects on histone post-
translational modifications in nuclei from dopamine receptor 
1 (D1R)-expressing cells or in nuclei from cells expressing the 
dopamine receptor 2 (D2R).
Emiliana Borrelli (UCI) discussed the exciting possibility 
that neurological epigenetic effects could be induced by dys-
functional neurotransmitter’s control of brain functions. She 
presented results from studies of dopamine receptor D2R con-
ditional knockout mice in which D2R expression is lost spe-
cifically in presynaptic neurons. These animals appear to be 
excellent models of psychosis and schizophrenia, as suggested 
by their specific behaviors, which mimic the symptoms of these 
human neurological disorders. Analysis of RNA extracted from 
the frontal cortex, an area shown to be involved in schizophrenia, 
showed that almost 2,000 (out of a total of 25,000) RNAs were 
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